News

STARBIA MEDiTEK Co., Ltd. successfully passed Taiwanʹs Food and Drug Administration (TFDA) Quality Management System (QMS) inspection in January 2026, confirming full compliance with medical device quality management standards. The certification involved comprehensive on-site inspections and document reviews across all critical areas—facilities, equipment, organizational structure, production processes, quality control, storage and distribution, and customer complaint handling. This milestone validates both our operational excellence and our ongoing commitment to quality management. QMS certification confirms that STARBIA MEDiTEK has established a robust quality management system ensuring consistent product quality and reliability. This qualification enables us to proceed with medical device license applications as we continue advancing our product certification efforts. Through precision and rigor, STARBIA MEDiTEK remains dedicated to continuous improvement of our quality management system, delivering accurate and reliable body composition analysis solutions to users worldwide.

STARBIA MEDiTEK Co., Ltd. has been awarded the 2025 National Innovation Advancement Award by the Research Center for Biotechnology and Medicine Policy. The honor recognizes the companyʹs sustained innovation in bioelectrical impedance analysis (BIA) body composition technology.

STARBIA MEDiTEK extends sincere gratitude to the Taiwan External Trade Development Council (TAITRA) for their recognition and support, enabling STARBIA to represent Taiwan at MEDICA 2025, the worldʹs largest medical equipment exhibition, and showcase Taiwanʹs innovative strength in medical technology to the international market.

November 18, 2025 – STARBIA MEDiTEK has been approved by the National Science and Technology Councilʹs Science Park Review Committee to establish operations in the Huwei Park of the Central Taiwan Science Park, with a planned investment of NT$20 million.

In preparation for the AFC U-17 Asian Cup Saudi Arabia 2026 Qualifiers scheduled for late November, the Chinese Taipei U17 Menʹs Football Team has officially partnered with STARBIA MEDiTEK to integrate StarBIAʹs latest athlete body composition analysis technology (SA-701C), establishing more precise scientific training indicators for the national team.

STARBIA MEDiTEK Co., Ltd. is honored to announce that we will be participating in MEDICA 2025, the worldʹs largest medical technology trade fair, at Messe Düsseldorf, Germany, from November 17 (Mon) to November 20 (Thu), 2025.

The 2025 Healthy Ageing Tech Show has concluded successfully! We showcased our flagship products, STARBIA 701 and STARBIA 201, and our 701 model drew the most interest at the event, attracting many visitors who were eager to try it.

STARBIA MEDiTEK will participate in the "Taiwan Healthy Ageing Tech Show 2025" at Taipei World Trade Center Hall 1 from August 8-10, 2025, showcasing our STARBIA body composition analyzer series and bringing breakthrough technological innovation to Taiwan′s aging health industry.

STARBIA MEDiTEK Participates in BIO Asia–Taiwan 2025

STARBIA MEDiTEK Joins Taiwan Health Technology Center in Malaysia